Modern approaches to drug therapy of bladder cancer after first progression.
The number of drugs that is effective in urothelial cancer is very little. Cisplatin remains the basic drug for first line, but its use may be limited because of significant toxic reactions, that develop in a great number of patients. In case of impossibility of use of platinum derivatives treatment...
Main Authors: | L. V. Bolotina, L. A. Koroleva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
QUASAR, LLC
2015-06-01
|
Series: | Issledovaniâ i Praktika v Medicine |
Subjects: | |
Online Access: | https://www.rpmj.ru/rpmj/article/view/60 |
Similar Items
-
Bladder cancer. A retrospective analysis of the use of vinfluvin in real clinical practice
by: A. S. Zhabina, et al.
Published: (2021-06-01) -
CLINICAL CASE OF MULTIMODALITY TREATMENT OF METASTATIC BLADDER CANCER
by: A. V. Lykov, et al.
Published: (2020-01-01) -
CLINICAL CASE OF TREATMENT OF INVASIVE UROTHELIAL CANCER OF THE UPPER URINARY TRACT. PROBLEMS OF COMBINED TREATMENT
by: A. A. Klimenko, et al.
Published: (2018-03-01) -
A case of myocardial metastasis of bladder cancer
by: D. V. Shatov, et al.
Published: (2021-01-01) -
Organ-Preserving Surgery in Urethral Cancer (a Clinical Case)
by: N. S. Kholopova, et al.
Published: (2021-12-01)